查看文章

Reports an error in" Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: A systematic review and meta-analysis" by Nicola Black, Emily Stockings, Gabrielle Campbell, Lucy T. Tran, Dino Zagic, Wayne D. Hall, Michael Farrell and Louisa Degenhardt (The Lancet Psychiatry, 2019 [Dec], Vol 6 [12], 995-1010). The appendix of the original article has been corrected as of Dec 19, 2019.(The following abstract of the original article appeared in record 2020-09220-014). Medicinal cannabinoids, including medicinal cannabis and pharmaceutical cannabinoids and their synthetic derivatives, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), have been suggested to have a therapeutic role in certain mental disorders. We analysed the available evidence to ascertain the effectiveness and safety of all types of medicinal cannabinoids in treating symptoms of various mental disorders …